Enanta Pharmaceuticals, Inc. (ENTA)
13.51
-0.49
(-3.50%)
USD |
NASDAQ |
Feb 20, 16:00
13.65
+0.14
(+1.04%)
After-Hours: 20:00
Enanta Pharmaceuticals Market Cap : 392.05M for Feb. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Agios Pharmaceuticals, Inc. | 1.714B |
| ACADIA Pharmaceuticals, Inc. | 4.059B |
| Alnylam Pharmaceuticals, Inc. | 44.59B |
| Savara, Inc. | 1.125B |
| BioMarin Pharmaceutical, Inc. | 12.31B |
Market Cap Related Metrics
| PS Ratio | 4.682 |
| Price to Book Value | 3.097 |
| Price | 13.51 |
| Earnings Yield | -23.72% |